Luye Pharma Group today announced that the first subject has been enrolled in a Phase 1 clinical trial in China for its LY03021, which was filed through China's Class 1 pathway for innovative drugs.

GRANDVIEW, Mo. (KCTV) - A large stretch of Blue Ridge Boulevard will soon see major renovations between Prospect Ave. and ...

The next phase of the new law that ultimately will introduce a demerit system that can strip repeat offenders of their ...

Parts of the European Commission's much-anticipated AI Act come into force this weekend. It's been hailed as the first piece ...

RETAIL prices of rice and pork both dropped in the second phase of last month (July 15-17), according to the Philippine Statistics Authority.

The Meralco PowerGen Corp. (MGen) is gunning for over 10,346 megawatts (MW) of net sellable capacity by 2030, double than the 5,068 MW it recorded last month, as it scales up investments in both ...

Lionel Messi left injured in the 11th minute but Inter Miami earned a 5-4 penalty shootout win against visiting Necaxa ...

Nebius' operational positioning in Europe has strong cost advantages vs. Big Tech hyperscalers. Read why NBIS stock is a ...

A largely grant-funded project aims to connect over 120 City of Yakima households to City utilities.The Expanding Water and Wastewater Access to Underserved Com ...

The first section of the water distribution ring pipe was recently installed in the machine pit at the Datang Zala Hydropower ...

Compass Pathways fell on Phase 3 data but remains on track for an FDA filing despite dilution risks and volatility. Find out ...

Mutuum Finance (MUTM) is surging through its presale, raising over $13.9 million and attracting 14,800 holders with tokens ...